Lim Jaechul, Ha Minju, Chang Hyeshik, Kwon S Chul, Simanshu Dhirendra K, Patel Dinshaw J, Kim V Narry
Center for RNA Research, Institute for Basic Science, Seoul 151-742, Korea; School of Biological Sciences, Seoul National University, Seoul 151-742, Korea.
Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Cell. 2014 Dec 4;159(6):1365-76. doi: 10.1016/j.cell.2014.10.055.
Uridylation occurs pervasively on mRNAs, yet its mechanism and significance remain unknown. By applying TAIL-seq, we identify TUT4 and TUT7 (TUT4/7), also known as ZCCHC11 and ZCCHC6, respectively, as mRNA uridylation enzymes. Uridylation readily occurs on deadenylated mRNAs in cells. Consistently, purified TUT4/7 selectively recognize and uridylate RNAs with short A-tails (less than ∼ 25 nt) in vitro. PABPC1 antagonizes uridylation of polyadenylated mRNAs, contributing to the specificity for short A-tails. In cells depleted of TUT4/7, the vast majority of mRNAs lose the oligo-U-tails, and their half-lives are extended. Suppression of mRNA decay factors leads to the accumulation of oligo-uridylated mRNAs. In line with this, microRNA induces uridylation of its targets, and TUT4/7 are required for enhanced decay of microRNA targets. Our study explains the mechanism underlying selective uridylation of deadenylated mRNAs and demonstrates a fundamental role of oligo-U-tail as a molecular mark for global mRNA decay.
尿苷酸化广泛存在于信使核糖核酸(mRNA)上,但其机制和意义仍不清楚。通过应用TAIL-seq技术,我们鉴定出TUT4和TUT7(TUT4/7),它们分别也被称为ZCCHC11和ZCCHC6,是mRNA尿苷酸化酶。尿苷酸化在细胞内的去腺苷酸化mRNA上很容易发生。同样,纯化后的TUT4/7在体外能选择性地识别并使具有短A尾(小于约25个核苷酸)的RNA发生尿苷酸化。聚腺苷酸结合蛋白C1(PABPC1)拮抗多聚腺苷酸化mRNA的尿苷酸化,这有助于对短A尾的特异性识别。在缺乏TUT4/7的细胞中,绝大多数mRNA失去了寡聚U尾,并且它们的半衰期延长。抑制mRNA降解因子会导致寡聚尿苷酸化mRNA的积累。与此一致的是,微小RNA会诱导其靶标的尿苷酸化,并且TUT4/7是增强微小RNA靶标降解所必需的。我们的研究解释了去腺苷酸化mRNA选择性尿苷酸化的潜在机制,并证明了寡聚U尾作为全球mRNA降解的分子标记的基本作用。